Articles

Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI

Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, UK
Institute for Cardiovascular and Metabolic Research, Harborne Building, University of Reading, UK
Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, UK
Institute for Cardiovascular and Metabolic Research, Harborne Building, University of Reading, UK
Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, UK
Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, UK
ACRF Department of Cancer Biology and Therapeutics, John Curtin School of Medical Research, Australian National University, Canberra, ACT, 2601, Australia
Department of Immunology, Heartlands Hospital, Birmingham, UK
Department of Immunology, Heartlands Hospital, Birmingham, UK
Department of Biochemistry, University of Cambridge, UK
Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, UK
Institute for Cardiovascular and Metabolic Research, Harborne Building, University of Reading, UK
Department of Biosciences, College of Life and Environmental Sciences, University of Birmingham, UK
Department of Haematology, Queen Elizabeth Hospital, Birmingham, UK
Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, UK;Centre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, Midlands, UK
Vol. 103 No. 12 (2018): December, 2018 https://doi.org/10.3324/haematol.2018.193391